Robert F. Apple, Executive Vice President & CFO at ANTARES PHARMA, INC. (ATRS), sold 25,000 shares at $4.01 ($100K) on 2013-01-08, disclosed to the SEC on 2013-01-10.
Scheduled sale ($100k) by Executive Vice President & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |